Provided by Tiger Trade Technology Pte. Ltd.

Alamar Biosciences

34.24
-0.4000-1.15%
Post-market: 34.00-0.2400-0.70%18:47 EDT
Volume:212.39K
Turnover:7.43M
Market Cap:2.37B
PE:-47.82
High:36.10
Open:34.93
Low:34.14
Close:34.64
52wk High:38.54
52wk Low:18.85
Shares:69.31M
Float Shares:12.94M
Volume Ratio:0.69
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7160
EPS(LYR):-2.5873
ROE:-33.57%
ROA:-13.53%
PB:7.59
PE(LYR):-13.23

Loading ...

Company Profile

Company Name:
Alamar Biosciences
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
286
Office Location:
47071 Bayside Parkway,Fremont,California,United States
Zip Code:
94538
Fax:
(510) 605-5062
Introduction:
Alamar Biosciences, Inc. was incorporated in Delaware on May 7, 2018, and is headquartered in Fremont, California. The company is a commercial-stage proteomics company dedicated to establishing the gold standard in protein detection and analysis. It offers the proprietary NULISA platform, which enables "precision proteomics" by detecting low-abundance protein biomarkers in non-invasive biofluids with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range, and automation. The company provides integrated solutions comprising instruments, consumables, and analytical software for discovery, translational research, and diagnostic development.

Directors

Name
Position
Yuling Luo
Chief Executive Officer and Chairman
Shiping Chen
Chief Operating Officer and Director
Frank R. Witney
Director
Ian W. Ratcliffe
Director
Nicholas Naclerio
Director
Rebecca Chambers
Director

Shareholders

Name
Position
Yuling Luo
Chief Executive Officer and Chairman
Shiping Chen
Chief Operating Officer and Director
Justin McAnear
Chief Financial Officer
Timothy White
President